FMI and EPFL Map the Druggable CRBN Interactome

Institutions: Friedrich Miescher Institute & EPFL · Event Type: Peer-Reviewed Publication (Nature Biotechnology) · Technology: Proteome-Wide Molecular Glue Interactome Mapping · Target: Cereblon (CRBN) · Publication Date: August 13, 2026 Summary Researchers from the Friedrich Miescher Institute, EPFL and collaborators mapped a latent cereblon molecular-glue…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Astellas / AviadoBio – Gene Therapy Program Sustained via Nonprofit Funding
Samsung Biologics Moves Into Peptide Manufacturing
Boulevard Bio Launches with $65 Million
GSK – $1B SiranBio Oligo Deal